Two Sigma Investments, LP Arbutus Biopharma Corp Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Two Sigma Investments, LP holds 29,726 shares of ABUS stock, worth $94,528. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,726

Previous 14,886 99.69%

Holding current value

$94,528

Previous $45,000 153.33%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.12 - $4.56 $46,300 - $67,670	14,840 Added 99.69%	29,726 $114,000
Q2 2024 Aug 14, 2024	SELL	$2.52 - $3.63 $209,235 - $301,398	-83,030 Reduced 84.8%	14,886 $45,000
Q1 2024 May 15, 2024	SELL	$2.26 - $2.92 $239,376 - $309,283	-105,919 Reduced 51.96%	97,916 $252,000
Q4 2023 Feb 14, 2024	BUY	$1.69 - $2.54 $301,703 - $453,448	178,523 Added 705.29%	203,835 $509,000
Q3 2023 Nov 14, 2023	SELL	$1.9 - $2.27 $68,382 - $81,699	-35,991 Reduced 58.71%	25,312 $51,000
Q2 2023 Aug 14, 2023	SELL	$2.24 - $3.06 $690,981 - $943,930	-308,474 Reduced 83.42%	61,303 $140,000
Q1 2023 May 15, 2023	BUY	$2.23 - $3.1 $824,602 - $1.15 Million	369,777 New	369,777 $1.12 Million
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $45,950 - $70,392	24,442 New	24,442 $47,000
Q2 2022 Aug 15, 2022	SELL	$1.98 - $3.17 $235,780 - $377,486	-119,081 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.42 - $3.98 $1.85 Million - $3.05 Million	-766,456 Reduced 86.55%	119,081 $355,000
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $482,793 - $715,651	155,239 Added 21.26%	885,537 $3.45 Million
Q3 2021 Nov 15, 2021	BUY	$2.65 - $4.62 $1.26 Million - $2.2 Million	476,475 Added 187.72%	730,298 $3.13 Million
Q2 2021 Aug 16, 2021	SELL	$2.5 - $3.51 $1.29 Million - $1.81 Million	-515,228 Reduced 67.0%	253,823 $769,000
Q1 2021 May 17, 2021	BUY	$3.14 - $4.84 $2.41 Million - $3.72 Million	769,051 New	769,051 $2.56 Million
Q3 2020 Nov 16, 2020	SELL	$1.75 - $6.2 $496,137 - $1.76 Million	-283,507 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.91 - $2.36 $64,707 - $167,812	71,107 Added 33.48%	283,507 $516,000
Q1 2020 May 15, 2020	BUY	$1.01 - $3.42 $122,751 - $415,653	121,536 Added 133.76%	212,400 $215,000
Q4 2019 Feb 14, 2020	BUY	$0.87 - $2.89 $59,390 - $197,285	68,265 Added 302.07%	90,864 $253,000
Q3 2019 Nov 14, 2019	SELL	$1.34 - $2.4 $87,779 - $157,216	-65,507 Reduced 74.35%	22,599 $34,000
Q2 2019 Aug 14, 2019	BUY	$1.46 - $4.44 $36,167 - $109,987	24,772 Added 39.11%	88,106 $183,000
Q1 2019 May 15, 2019	BUY	$3.41 - $4.57 $37,475 - $50,224	10,990 Added 21.0%	63,334 $227,000
Q4 2018 Feb 14, 2019	BUY	$3.5 - $9.66 $98,465 - $271,764	28,133 Added 116.2%	52,344 $200,000
Q3 2018 Nov 14, 2018	BUY	$7.85 - $12.35 $190,056 - $299,005	24,211 New	24,211 $229,000
Q2 2018 Aug 14, 2018	BUY	$5.0 - $7.35 $363,570 - $534,447	72,714 New	72,714 $531,000
Q1 2018 May 15, 2018	SELL	$4.4 - $6.05 $187,726 - $258,123	-42,665 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.45 - $7.7 $189,859 - $328,520	42,665	42,665 $215,000

Others Institutions Holding ABUS

# of Institutions

155

Shares Held

99.5M

Call Options Held

2.31M

Put Options Held

525K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $477M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Arbutus Biopharma Corp Transaction History